Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
/in Dendritic Cells, International Publications /von 2006-10-12 / Blood 2007 Feb;109(3):1165-73Current status of immunotherapy in B cell malignancies
/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-7Dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications /von 2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-413Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-01 / Endocr. Relat. Cancer 2006 Sep;13(3):779-95Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2006-08-16 / J Transl Med 2006 Aug;4:36HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination
/in Breast Cancer, Dendritic Cells, International Publications /von 2006-05-25 / Gene Ther. 2006 Oct;13(19):1391-402Virology- and immunology-based gene therapy for cancer
/in Dendritic Cells, International Publications /von 2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-5[Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma–a report of ten cases]
/in Dendritic Cells, Hypernephroma, International Publications /von 2006-05-01 / Ai Zheng 2006 May;25(5):625-30
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de